These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 179131)

  • 1. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
    Axelsen NH; Harboe M; Jonsson V; Videbaek AA
    Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects.
    Jonsson V; Videbek A; Axelsen NH; Harboe M
    Scand J Haematol; 1976 Mar; 16(3):209-17. PubMed ID: 179130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunochemical study of serum in the diagnosis of mu-chain disease].
    Chernokhvostova EV; Batalova TN; Andreeva NE; Antipova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):42-8. PubMed ID: 404805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new case of heavy mu-chain disease.
    Danon F; Mihaesco C; Bouvry M; Clerc M; Seligmann M
    Scand J Haematol; 1975 Aug; 15(1):5-9. PubMed ID: 170667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunofixation in agarose gel for the identification of monoclonal immunoglobulins].
    Potdevin F; Roncato M; Drupt F; Paris M; Leclerc M
    Ann Immunol (Paris); 1983; 134C(1):105-23. PubMed ID: 6407384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new case of mu heavy chain disease: clinical and immunochemical studies.
    Dammacco F; Bonomo L; Franklin EC
    Blood; 1974 May; 43(5):713-9. PubMed ID: 4206914
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD).
    Wetter O; Drosdziok W; Müller B
    Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of several immunochemical approaches for the screening of alpha chain disease.
    Orr KB
    Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-chain disease.
    Franklin EC
    Arch Intern Med; 1975 Jan; 135(1):71-2. PubMed ID: 1111471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy chain disease of the gamma (gamma M) type: report of the first case.
    Forte FA; Prelli F; Yount WJ; Jerry LM; Kochwa S; Franklin EC; Kunkel HG
    Blood; 1970 Aug; 36(2):137-44. PubMed ID: 4193528
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic lymphocytic leukaemia and IgG heavy chain disease.
    Briët E; van Nieuwkoop JA; Jol-vd Zijde CM; den Ottolander GJ; Rádl J
    Scand J Haematol; 1980 Sep; 25(3):244-50. PubMed ID: 7008181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain.
    Frangione B; Franklin EC; Prelli F
    Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new variant of heavy-chain disease (mu-chain disease).
    Ballard HS; Hamilton LM; Marcus AJ; Illes CH
    N Engl J Med; 1970 May; 282(19):1060-2. PubMed ID: 5438427
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical and biochemical study of a human Fcmu-like fragment (mu-chain disease).
    Lebreton JP; Ropartz C; Rousseaus J; Roussel P; Dautrevaus M; Biserte G
    Eur J Immunol; 1975 Mar; 5(3):179-84. PubMed ID: 824130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Difficulties in the identification of serum M-component].
    Nikolić V; Nikolić B; Milosević-Jovcić N; Vitić J
    Bilt Hematol Transfuz; 1977; 5(2):37-42. PubMed ID: 415732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cast nephropathy in mu heavy chain disease.
    Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
    Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu-chain disease.
    Lee SL; Rosner F; Ruberman W; Glasberg S
    Ann Intern Med; 1971 Sep; 75(3):407-14. PubMed ID: 5568152
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
    Whicher JT; Wallage M; Fifield R
    Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.